| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.0092 |
0.9 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |